Online Exclusives

Online Exclusives

Analysis on COVID-19 Clinical Trials Reveals Disorganization and Wasted Resources

An analysis cosponsored by STAT and AppliedXL, a Newlab Venture Studio company, found that clinical trials for treatments and preventative strategies for COVID-19 were...

New FDA Platform Criticized for Lack of Demographic Information

The new FDA platform, Project Patient Voice, is a public database of patient-reported outcomes for clinical trials of cancer treatments intended to give patients...

Congress Seeks Formal Investigation Into Foreign Investment in US Pharmaceutical Industry

On June 30, Senators Elizabeth Warren (D-MA) and Marco Rubio (R-FL) introduced the U.S. Pharmaceutical Supply Chain Review Act, calling for a formal investigation...

FDA Approves New HIV Treatment for Patients With Restricted Treatment Options

The FDA has approved fostemsavir for adult patients with HIV who have tried multiple medications and whose HIV infection cannot be successfully treated with...

White House Further Suspends Work Visas, Affecting Science and Tech

The White House has announced the restriction of several categories of work visas for non-American citizens, in response to high unemployment levels following the...

FDA Approves Oral Selinexor for Relapsed/Refractory DLBCL

The FDA has granted accelerated approval to selinexor for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL...

Health Care Sector Sees Dramatic Drop in Spending in April

An analysis published by the consulting firm Altarum found that national spending on health care services was down 24% in April 2020 compared to...

Dexamethasone Lowers Death Rate Among Ventilated COVID-19 Patients

Low-dose dexamethasone appeared to reduce death by up to one-third in hospitalized patients with severe COVID-19, according to new data pre-published online to the...

FDA Releases Statistical Guidance for Clinical Trials Affected by COVID-19

The FDA has released new guidance regarding statistical considerations for clinical trials affected by the COVID-19 pandemic, with the aim of maintaining integrity of...

NCI Director Encourages Reopening of Cancer Care to Prevent Future Health Crisis

In an editorial published in Science, National Cancer Institute (NCI) Director Norman Sharpless, MD, encouraged cancer screenings, treatment, and research to reopen, with proper...
Advertisement

Current Issue

July 2020 Volume 6 Issue 8

This issue discusses palliative care and hematopoietic cell transplant, examines anticoagulation in patients with obesity, and more.